Skip to main content
Article
Substantial Improvement in a Meige’s Syndrome Patient with Levetiracetam Treatment
Movement Disorder (2004)
  • Kelly L. Sullivan, University of South Florida
  • Theresa A. Zesiewicz, University of South Florida
  • Elan D. Louis, Columbia University
  • Martin Menkin, Orlando Regional Medical Center
  • Peter B. Dunne, University of South Florida
  • Robert A. Hauser, University of South Florida
Abstract
We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia. © 2004 Movement Disorder Society.
Keywords
  • Meige's Sydrome,
  • Patient,
  • Levetiracetam treatment
Disciplines
Publication Date
December 19, 2004
DOI
10.1002/mds.20233
Citation Information
Kelly L. Sullivan, Theresa A. Zesiewicz, Elan D. Louis, Martin Menkin, et al.. "Substantial Improvement in a Meige’s Syndrome Patient with Levetiracetam Treatment" Movement Disorder Vol. 19 Iss. 12 (2004) p. 1518 - 1521 ISSN: 1531-8257
Available at: http://works.bepress.com/kelly_sullivan/111/